ArticleCancers2022
Daratumumab Improves Bone Turnover in Relapsed/Refractory Multiple Myeloma; Phase 2 Study "REBUILD".
Evangelos Terpos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it
ArticleCancers2022
Evangelos Terpos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.